[37] [38] See also [edit source] Dipeptidyl peptidase-4 Gastric inhibitory polypeptide GLP-1 receptor agonistsalbiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide, and semaglutide, the last of which is marketed under the brands Ozempic, Rybelsus, and Wegovy
These reports are uncommon and often involve patients with pre-existing liver conditions, concurrent medications, or other confounding factors
When discontinued, appetite returns typically to or near pre-treatment levels and most patients regain a significant proportion of lost weight over 1218 months without the medication
Gastric bypass surgery will usually result in quicker weight loss but data show that at the 24-month point, the numbers are pretty similar
He urges consumers to be wary and calls upon the FDA to take stronger regulatory action